Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Point of Care Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Introduction of CLIA waived tests
3.2.1.2. Rise in funding from government and private institutions
3.2.1.3. Growing geriatric population base
3.2.1.4. Growing prevalence of target diseases
3.2.1.5. Growing demand for home healthcare and The introduction of advanced technology-enabled products
3.2.2. Market restraint analysis
3.2.2.1. High procedure costs coupled with limited adoption of POC devices in certain emerging regions
3.2.2.2. Presence of ambiguous regulatory as well as reimbursement framework for primary care setting
3.2.3. Market challenge analysis
3.2.3.1. POC device pose challenges in maintaining The quality standards
3.2.4. Market opportunity analysis
3.3. in Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of The suppliers
3.3.1.2. Bargaining power of The buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Reimbursement Overview of IVDs and LDTs
3.5. Pricing Analysis
Chapter 4. Point of Care Diagnostics Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Point of Care Diagnostics Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
4.4.1. Glucose Testing
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Hb1Ac Testing
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.3. Coagulation Testing
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.4. Fertility/Pregnancy Testing
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5. Infectious Disease
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.2. HIV POC
4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.3. Clostridium Difficile POC
4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.4. HBV POC
4.4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.5. Pneumonia or Streptococcus Associated Infections
4.4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.6. Respiratory Syncytial Virus (RSV) POC
4.4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.7. HPV POC
4.4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.8. Influenza/Flu POC
4.4.5.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.9. HCV POC
4.4.5.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.10. MRSA POC
4.4.5.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.11. TB and drug resistant TB POC
4.4.5.11.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.12. HSV POC
4.4.5.12.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.13. COVID-19
4.4.5.13.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5.14. Other infectious diseases
4.4.5.14.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.6. Cardiac Markers
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.7. Thyroid Stimulating Hormone
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.8. Hematology
4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.9. Primary Care Systems
4.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.10. Decentralized Clinical Chemistry
4.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.11. Feces
4.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.12. Lipid Testing
4.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.13. Cancer Marker
4.4.13.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.14. Blood Gas/Electrolytes
4.4.14.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.15. Ambulatory Chemistry
4.4.15.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.16. Drug of Abuse (DOA) Testing
4.4.16.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.17. Autoimmune diseases
4.4.17.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.18. Urinalysis/Nephrology
4.4.18.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. Point of Care Diagnostics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Point of Care Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
5.4.1. Clinics
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD billion)
5.4.1.2. Pharmacy & Retail Clinics
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.1.3. Physician Office
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.1.4. Urgent Care Clinics
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.1.5. Non-practice Clinics
5.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.2. Hospitals
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.3. Home
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.4. Assisted Living Healthcare Facilitates
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.5. Laboratory
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. Point of Care Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
6.6. Europe
6.6.1. Germany
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.6. Russia
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Russia market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.7. Norway
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.8. Sweden
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework/ reimbursement structure
6.6.9.3. Competitive scenario
6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
6.7.4. South Korea
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Global Company Market Share Analysis, 2024
7.4. Company Heat Map Analysis
7.5. Strategy Mapping
7.5.1. Expansion
7.5.2. Mergers & Acquisition
7.5.3. Partnerships & Collaborations
7.5.4. New Product Launches
7.5.5. Research and Development
7.6. Company Profiles
7.6.1. F. Hoffmann-La Roche Ltd.
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Qiagen
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Danaher Corporation
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Becton Dickinson (BD)
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. bioMérieux
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Abbott
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. Siemens Healthcare GmbH
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Werfen
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Nova Biomedical
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
7.6.10. Trividia Health, Inc.
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives
7.6.11. QuidelOrtho Corporation
7.6.11.1. Company overview
7.6.11.2. Financial performance
7.6.11.3. Product benchmarking
7.6.11.4. Strategic initiatives
7.6.12. Trinity Biotech
7.6.12.1. Company overview
7.6.12.2. Financial performance
7.6.12.3. Product benchmarking
7.6.12.4. Strategic initiatives
7.6.13. Sekisui Diagnostics
7.6.13.1. Company overview
7.6.13.2. Financial performance
7.6.13.3. Product benchmarking
7.6.13.4. Strategic initiatives
7.6.14. Orasure Technologies, Inc.
7.6.14.1. Company overview
7.6.14.2. Financial performance
7.6.14.3. Product benchmarking
7.6.14.4. Strategic initiatives
7.6.15. Spectral Medical, Inc.
7.6.15.1. Company overview
7.6.15.2. Financial performance
7.6.15.3. Product benchmarking
7.6.15.4. Strategic initiatives
7.6.16. EKF Diagnostics Holdings plc.
7.6.16.1. Company overview
7.6.16.2. Financial performance
7.6.16.3. Product benchmarking
7.6.16.4. Strategic initiatives
7.6.17. Anbio Biotechnology Co., Ltd.
7.6.17.1. Company overview
7.6.17.2. Financial performance
7.6.17.3. Product benchmarking
7.6.17.4. Strategic initiatives
7.6.18. AccuBioTech Co., Ltd
7.6.18.1. Company overview
7.6.18.2. Financial performance
7.6.18.3. Product benchmarking
7.6.18.4. Strategic initiatives
7.6.19. ALPHA LABORATORIES
7.6.19.1. Company overview
7.6.19.2. Financial performance
7.6.19.3. Product benchmarking
7.6.19.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global point of care diagnostics market, by region, 2018-2030 (USD Billion)
Table 4 Global point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 5 Global point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 6 North America point of care diagnostics market, by region, 2018-2030 (USD Billion)
Table 7 North America point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 8 North America point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 9 U.S. point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 10 U.S. point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 11 Canada point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 12 Canada point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 13 Mexico point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 14 Mexico point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 15 Europe point of care diagnostics market, by region, 2018-2030 (USD Billion)
Table 16 Europe point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 17 Europe point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 18 Germany point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 19 Germany point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 20 UK point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 21 UK point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 22 France point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 23 France point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 24 Italy point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 25 Italy point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 26 Spain point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 27 Spain point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 28 Denmark point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 29 Denmark point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 30 Sweden point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 31 Sweden point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 32 Norway point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 33 Norway point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 34 Asia Pacific point of care diagnostics market, by region, 2018-2030 (USD Billion)
Table 35 Asia Pacific point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 36 Asia Pacific point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 37 China point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 38 China point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 39 Japan point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 40 Japan point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 41 India point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 42 India point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 43 South Korea point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 44 South Korea point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 45 Australia point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 46 Australia point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 47 Thailand point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 48 Thailand point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 49 Latin America point of care diagnostics market, by region, 2018-2030 (USD Billion)
Table 50 Latin America point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 51 Latin America point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 52 Brazil point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 53 Brazil point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 54 Argentina point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 55 Argentina point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 56 MEA point of care diagnostics market, by region, 2018-2030 (USD Billion)
Table 57 MEA point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 58 MEA point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 59 South Africa point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 60 South Africa point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 61 Saudi Arabia point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 62 Saudi Arabia point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 63 UAE point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 64 UAE point of care diagnostics market, by end-use, 2018-2030 (USD Billion)
Table 65 Kuwait point of care diagnostics market, by product, 2018-2030 (USD Billion)
Table 66 Kuwait point of care diagnostics market, by end use, 2018-2030 (USD Billion)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Point of care diagnostics market: market outlook
Figure 14 Point of care diagnostics competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Point of care diagnostics market driver impact
Figure 20 Point of care diagnostics market restraint impact
Figure 21 Point of care diagnostics market strategic initiatives analysis
Figure 22 Point of care diagnostics market: Product movement analysis
Figure 23 Point of care diagnostics market: Product outlook and key takeaways
Figure 24 Glucose testing market estimates and forecast, 2018-2030
Figure 25 Hb1Ac testing market estimates and forecast, 2018-2030
Figure 26 Coagulation testing market estimates and forecast, 2018-2030
Figure 27 Fertility/pregnancy market estimates and forecast, 2018-2030
Figure 28 Infectious disease market estimates and forecast, 2018-2030
Figure 29 HIV POC market estimates and forecast, 2018-2030
Figure 30 Pneumonia or streptococcus associated infections market estimates and forecasts, 2018-2030
Figure 31 Respiratory syncytial virus (RSV) POC market estimates and forecasts, 2018-2030
Figure 32 HPV POC market estimates and forecasts, 2018-2030
Figure 33 Influenza/ flu POC market estimates and forecasts, 2018-2030
Figure 34 HCV POC market estimates and forecasts, 2018-2030
Figure 35 MRSA POC market estimates and forecasts, 2018-2030
Figure 36 TB and drug resistant TB POC market estimates and forecasts, 2018-2030
Figure 37 HSV POC market estimates and forecasts, 2018-2030
Figure 38 COVID-19 market estimates and forecasts, 2018-2030
Figure 39 Other infectious diseases estimates and forecasts, 2018-2030
Figure 40 Cardiac markers market estimates and forecasts, 2018-2030
Figure 41 Thyroid stimulating hormone market estimates and forecasts, 2018-2030
Figure 42 Hematology market estimates and forecasts, 2018-2030
Figure 43 Primary care systems estimates and forecasts, 2018-2030
Figure 44 Decentralized clinical chemistry market estimates and forecasts, 2018-2030
Figure 45 Feces market estimates and forecasts, 2018-2030
Figure 46 Lipid testing market estimates and forecasts, 2018-2030
Figure 47 Cancer marker estimates and forecasts, 2018-2030
Figure 48 Blood gas/ electrolytes market estimates and forecasts, 2018-2030
Figure 49 Ambulatory chemistry market estimates and forecasts, 2018-2030
Figure 50 Drug of abuse (DoA) testing market estimates and forecasts, 2018-2030
Figure 51 Autoimmune diseases market estimates and forecasts, 2018-2030
Figure 52 Urinalysis/nephrology market estimates and forecasts, 2018-2030
Figure 53 Point of care diagnostics market: end use movement analysis
Figure 54 Point of care diagnostics market: end use outlook and key takeaways
Figure 55 Clinics market estimates and forecasts, 2018-2030
Figure 56 Pharmacy & retail clinics market estimates and forecasts, 2018-2030
Figure 57 Physician office market estimates and forecasts, 2018-2030
Figure 58 Urgent care clinics market estimates and forecasts, 2018-2030
Figure 59 Non-practice clinics market estimates and forecasts, 2018-2030
Figure 60 Hospitals market estimates and forecasts, 2018-2030
Figure 61 Home market estimates and forecasts, 2018-2030
Figure 62 Assisted living healthcare facilities market estimates and forecasts, 2018-2030
Figure 63 Laboratory market estimates and forecasts, 2018-2030
Figure 64 Global point of care diagnostics market: Regional movement analysis
Figure 65 Global point of care diagnostics market: Regional outlook and key takeaways
Figure 66 Global point of care diagnostics market share and leading players
Figure 67 North America market share and leading players
Figure 68 Europe market share and leading players
Figure 69 Asia Pacific market share and leading players
Figure 70 Latin America market share and leading players
Figure 71 Middle East & Africa market share and leading players
Figure 72 North America: SWOT
Figure 73 Europe SWOT
Figure 74 Asia Pacific SWOT
Figure 75 Latin America SWOT
Figure 76 MEA SWOT
Figure 77 North America, by country
Figure 78 North America
Figure 79 North America market estimates and forecasts, 2018-2030
Figure 80 U.S. key country dynamics
Figure 81 U.S. market estimates and forecasts, 2018-2030
Figure 82 Canada country dynamics
Figure 83 Canada market estimates and forecasts, 2018-2030
Figure 84 Mexico country dynamics
Figure 85 Mexico market estimates and forecasts, 2018-2030
Figure 86 Europe
Figure 87 Europe market estimates and forecasts, 2018-2030
Figure 88 UK country dynamics
Figure 89 UK market estimates and forecasts, 2018-2030
Figure 90 Germany country dynamics
Figure 91 Germany market estimates and forecasts, 2018-2030
Figure 92 France country dynamics
Figure 93 France market estimates and forecasts, 2018-2030
Figure 94 Italy country dynamics
Figure 95 Italy market estimates and forecasts, 2018-2030
Figure 96 Spain country dynamics
Figure 97 Spain market estimates and forecasts, 2018-2030
Figure 98 Denmark country dynamics
Figure 99 Denmark market estimates and forecasts, 2018-2030
Figure 100 Sweden country dynamics
Figure 101 Sweden market estimates and forecasts, 2018-2030
Figure 102 Norway country dynamics
Figure 103 Norway market estimates and forecasts, 2018-2030
Figure 104 Asia Pacific
Figure 105 Asia Pacific market estimates and forecasts, 2018-2030
Figure 106 China country dynamics
Figure 107 China market estimates and forecasts, 2018-2030
Figure 108 Japan country dynamics
Figure 109 Japan market estimates and forecasts, 2018-2030
Figure 110 India country dynamics
Figure 111 India market estimates and forecasts, 2018-2030
Figure 112 Thailand country dynamics
Figure 113 Thailand market estimates and forecasts, 2018-2030
Figure 114 South Korea country dynamics
Figure 115 South Korea market estimates and forecasts, 2018-2030
Figure 116 Australia country dynamics
Figure 117 Australia market estimates and forecasts, 2018-2030
Figure 118 Thailand country dynamics
Figure 119 Thailand market estimates and forecasts, 2018-2030
Figure 120 Latin America
Figure 121 Latin America market estimates and forecasts, 2018-2030
Figure 122 Brazil country dynamics
Figure 123 Brazil market estimates and forecasts, 2018-2030
Figure 124 Argentina country dynamics
Figure 125 Argentina market estimates and forecasts, 2018-2030
Figure 126 Middle East and Africa
Figure 127 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 128 South Africa country dynamics
Figure 129 South Africa market estimates and forecasts, 2018-2030
Figure 130 Saudi Arabia country dynamics
Figure 131 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 132 UAE country dynamics
Figure 133 UAE market estimates and forecasts, 2018-2030
Figure 134 Kuwait country dynamics
Figure 135 Kuwait market estimates and forecasts, 2018-2030
Figure 136 Market share of key market players- Point of care diagnostics market
